News
-
-
-
PRESS RELEASE
Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines
Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines in a licensing agreement for emicizumab biosimilar worth USD 5.7 billion -
-
-
PRESS RELEASE
Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP-1 medicine
Sandoz receives regulatory approval for generic semaglutide in Canada, expanding patient access to key GLP-1 medicine. Approval paves way for affordable treatment option in Canada -
-
-
-